A user transitioned to a combination blend of CJC-1295, Ipamorelin, and GHRP-2 at a total dosage of 300mcg. They sought feedback on potential side effects after moving from a standard CJC/Ipamorelin mix.
A user transitioned to a combination blend of CJC-1295, Ipamorelin, and GHRP-2 at a total dosage of 300mcg. They sought feedback on potential side effects after moving from a standard CJC/Ipamorelin mix.